Healthcare IT News May 11, 2020
Nathan Eddy

Despite his high profile and the deep pockets of its investors, the Amazon, Berkshire Hathaway and JP Morgan Chase joint venture has so far shown limited progress on its aspirational tech-driven healthcare goals.

Atul Gawande, who in 2018 was appointed CEO of Haven, the nonprofit healthcare venture launched by the founders of Amazon, JP Morgan Chase & Co. and Berkshire Hathaway, is in “advanced discussions” to step down from the role, according to a Dow Jones report.

WHY IT MATTERS
Dr. Gawande, a surgeon and Harvard professor, was tapped to lead the then-unnamed joint venture nearly two years ago in 2018. Haven’s much-publicized debut positioned it as a disruptive force in the healthcare industry that would harness technology to lower costs...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Payer, Self-insured
It’s Time for Health Plans to Hold Behavioral Health Providers Accountable for Outcomes
Why 'intellectual curiosity' is key for payer CEOs
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
The Need for Payer Support in Overcoming Cancer Care Disparities
UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months

Share This Article